Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Smith ALW, Harmer CJ, Cowen PJ, et al. The serotonin 1A (5-HT(1A)) receptor as a pharmacological target in depression. CNS Drugs. 2023;37(7):571–85.
2. Bielski RJ, Cunningham L, Horrigan JP, et al. Gepirone extended-release in the treatment of adult outpatients with major depressive disorder: a double-blind, randomized, placebo-controlled, parallel-group study. J Clin Psychiatry. 2008;69(4):571–7.
3. World Health Organisation. Depressive disorder (depression). 2023. https://www.who.int/. Accessed 25 Oct 2023.
4. American Psychological Association. APA clinical practice guideline for the treatment of depression across three age cohorts. 2019. https://www.apa.org/. Accessed 25 Oct 2023.
5. Feiger AD, Heiser JF, Shrivastava RK, et al. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder. J Clin Psychiatry. 2003;64(3):243–9.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献